NCT01429233Unknown不适用
Real Life Experience of the Use of Isomers as ALENCAL(Levoamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
Closter Pharma1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2011年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Effect of therapy in the management of hypertension and other cardiovascular diseases
研究概览
简要总结
This is a Phase 4, observational, open study in patients whom their doctor for clinical practice prescribes levamlodipine. No medication was provided by the sponsor. The planned observation time is 8 weeks. The 8 weeks of observation involves an evaluation of baseline followed by information gathered from the assessment visits at week 4 and week 8, or clinical practice.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients whose primary physician based on their clinical condition and locally approved use will be eligible to participate in this study, and have been prescribe with Levamlodipine.
排除标准
- 未提供
结局指标
主要结局
Effect of therapy in the management of hypertension and other cardiovascular diseases
时间窗: 8 weeks
The change from Baseline in Blood Pressure at 8 weeks will be measure to evaluate th efficacy of the therapy.
次要结局
- Number of Participants with Adverse Events as a Measure of Safety and Tolerability(8 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian PatientsCoronary DiseaseHypertensionNCT01426594Closter Pharma2,000
已完成
4 期
Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)HIV-1-infectionNCT06104306Gilead Sciences33
已完成
4 期
A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA)Aortic DisordersCarotid DiseasePulmonary DiseasePeripheral Artery DiseaseNCT02596048Bracco Diagnostics, Inc224
已完成
4 期
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric PatientsPathological ProcessesNCT01092754Guerbet100
已完成
4 期
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.HypercholesterolemiaNCT06431763Novartis Pharmaceuticals402